Global Export of Heparin for Therapeutic Use Share by Country (Kilograms)

In 2023, China remains the dominant exporter of heparin for therapeutic use globally, accounting for a leading share. Brazil follows closely, showing a strong increase of 7.54% year-on-year, while the United States also indicates robust growth with a 3.55% rise. The Netherlands, despite being in the fourth position, experiences a slight decline. Switzerland and Armenia show significant growth rates of 13.33% and 69.47% respectively, indicating emerging potential. Conversely, substantial decreases are noted in Germany and Denmark. Over the last five years, various countries showed fluctuating trends, with some like South Africa and Pakistan experiencing notable declines.

Looking ahead, potential areas of growth include the United Arab Emirates and Slovakia, given their remarkable year-on-year increase. Innovations in pharmaceutical manufacturing, international trade policy changes, and global health crises may influence future trends. Monitoring shifts in the regulatory landscape and supply chain adjustments will be crucial for stakeholders in navigating the dynamic heparin export market.